Scapho 150mg Injection: View Uses, Side Effects, Price and …
Scapho 150mg Injection is used to treat a variety of conditions, such as psoriatic arthritis, ankylosing spondylitis, and psoriasis. It provides relief from swelling, pain, and redness associated with various disorders and improves physical function.
Scapho Injection - Uses, Dosage, Side Effects, Price, Composition
2019年8月14日 · Scapho Injection is an interleukin inhibitor used for the treatment of moderate to severe plaque psoriasis (a skin disease characterized by red, scaly patches on some areas of the body) in adults patients, where the systemic therapy is appropriate.
Scapho generic. Price of scapho. Uses, Dosage, Side effects - ndrugs
Scapho (Scapho) is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation. Scapho is used to treat moderate to severe plaque psoriasis (raised, silvery flaking of the skin), ankylosing spondylitis, and psoriatic arthritis in adults.
Scapho 150mg Injection - MrMed
Scapho 150mg Injection belongs to the monoclonal antibody category, containing the active ingredient Secukinumab. It treats moderate to severe plaque psoriasis, psoriatic arthritis and axial spondyloarthritis.
Secukinumab | Side-effects, uses, time to work - Versus Arthritis
Secukinumab is a type of drug known as a biological therapy. Your doctor may give it to you if you have: ankylosing spondylitis. It can also be used to treat psoriasis if it’s severe and other treatments haven’t worked.
Scapho Dosage/Direction for Use | MIMS Philippines
For patients who are anti-TNFα inadequate responders (IR) or patients with concomitant moderate to severe plaque psoriasis, the recommended dose is 300 mg by subcutaneous injection with initial dosing at Weeks 0, 1, 2, 3 and 4 followed by monthly maintenance dosing.
SCAPHO® is used to treat a skin condition called “plaque psoriasis”, which causes inflammation affecting the skin. SCAPHO® reduces the inflammation and other symptoms of the disease.
Novartis Launches Scapho Drug for the Treatment of Psoriasis - Medindia
2016年3月18日 · The generic name of Scapho is secukinumab, which is an injectable medicine and the first interleukin-17A (IL-17A) inhibitor to be approved in India. Switzerland-based pharmaceutical company,...
Secukinumab - StatPearls - NCBI Bookshelf
2023年6月20日 · Secukinumab is a novel biologic agent specifically targeting interleukin-17 (IL-17) involved in a pathological process. It is a fully human monoclonal antibody. Many clinical trials have demonstrated its efficacy in managing plaque psoriasis in 2015, psoriatic arthritis, and ankylosing spondylitis in 2016.
Novartis’ Scapho shows pioneering 4-year data in preventing …
2017年12月12日 · These new long-term data add to a growing body of evidence demonstrating the unique position of Scapho with lasting efficacy and proven safety across AS, psoriatic arthritis (PsA) and moderate-to-severe psoriasis. Scapho is the first and only IL …
- 某些结果已被删除